Background: Diabetes is a leading chronic disease globally. Additionally, it is a significant risk factor for cardiovascular diseases, which increases its morbidity and mortality. In spite of the presence of many pharmacological classes for ant diabetic agents, there is an annual update on their indications and use. This review article aimed at evaluating the literature on the updates in the new diabetes guidelines in 2020.
Methods: Medical databases were examined thoroughly to explore the eligible articles for inclusion. Twenty articles appeared in the search result. The produced reports were evaluated against the pre-decided inclusion criteria.
Results: After reviewing the literature, four articles were eligible to be included in this review. The included articles were published in 2019.
Conclusion: patient-centered approach should be used when choosing the individuals therapeutic plan. Atherosclerotic complications are a significant challenge in diabetes management.
Key words: Diabetes, guidelines, updates